DAN PUCKETT - 21 Feb 2023 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Chief Financial Officer
Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
21 Feb 2023
Net transactions value
-$1,635,600
Form type
4
Filing time
23 Feb 2023, 19:08:16 UTC
Previous filing
07 Feb 2023
Next filing
22 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $18,700 +1,100 +2.7% $17.00* 42,258 21 Feb 2023 Direct F1
transaction SWAV Common Stock Sale $212,124 -1,100 -2.6% $192.84 41,158 21 Feb 2023 Direct F1, F2
transaction SWAV Common Stock Tax liability $741,932 -3,847 -9.3% $192.86 37,311 21 Feb 2023 Direct F3
transaction SWAV Common Stock Sale $700,244 -3,653 -9.8% $191.69 33,658 22 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -1,100 -48% $0.000000 1,180 21 Feb 2023 Common Stock 1,100 $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022.
F2 All reported securities were sold at a price of $192.84.
F3 All reported securities were sold at a price of $192.86.
F4 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.